The ability of stem cells to continuously supply vast numbers of cells is magnificent, but it can be devastating if it runs amok, as in some tumours. So what makes a normal stem cell turn bad, and can it be redeemed?
References
Yilmaz, Ö. H. et al. Nature 441, 475–482 (2006).
Zhang, J. et al. Nature 441, 518–522 (2006).
Groszer, M. et al. Science 294, 2186–2189 (2001).
Groszer, M. et al. Proc. Natl Acad. Sci. USA 103, 111–116 (2006).
Cheng, T. et al. Science 287, 1804–1808 (2000).
Kippin, T. E., Martens, D. J. & van der Kooy, D. Genes Dev. 19, 756–767 (2005).
Seoane, J. et al. Cell 117, 211–223 (2004).
Essers, M. A. et al. Science 308, 1181–1184 (2005).
Sarbassov, D. D. et al. Mol. Cell 22, 159–168 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Janzen, V., Scadden, D. Good, bad and reformable. Nature 441, 418–419 (2006). https://doi.org/10.1038/441418b
Published:
Issue Date:
DOI: https://doi.org/10.1038/441418b
- Springer Nature Limited
This article is cited by
-
PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population
Tumor Biology (2016)
-
Urothelial carcinoma: Stem cells on the edge
Cancer and Metastasis Reviews (2009)
-
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Nature Genetics (2008)
-
Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program
Substance Abuse Treatment, Prevention, and Policy (2007)